JAMA Psychiatry

Papers
(The H4-Index of JAMA Psychiatry is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Combination Antidepressant Therapy vs Monotherapy—Further Considerations637
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey604
Assumptions and Limitations of the Synthetic Control Method360
Error in Results281
JAMA Psychiatry235
JAMA Psychiatry235
JAMA Psychiatry235
The Reliability of Traumatic and Adverse Experiences214
Diagnosing and Treating ADHD in Adults177
Overmystifying the Psychedelic Experience174
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode169
Error in Abstract161
Managerial and Organizational Challenges in the Age of AI156
Stop Counting Conversions—The Clinical High Risk for Psychosis Field Needs a New North Star150
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis150
An Opportunity to Advance Cannabis Science—DEA Rescheduling145
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance142
Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans140
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders140
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA135
Integrating Financing Variables Into Behavioral Health Policy Implementation Research134
Prenatal Adversities and Risk of Persistent Youth Psychopathology and Altered Cortical Thinning134
TikTok Challenges—Unintentional Injuries vs Suicide Attempts130
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder129
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression129
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression125
Patients Use AI—Clinicians Should Ask How124
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk121
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood116
JAMA Network Call for Papers on Health and the 2024 US Election110
JAMA Psychiatry109
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1107
Error in Byline106
Perinatal Mental Health Outcomes Following Natural Disasters105
Addiction Medicine Physicians and Medicinal Cannabinoids101
Searching the Brain for the Cause of Psychosis99
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression97
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction97
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving97
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers96
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness95
Semaglutide in Schizophrenia—A Top Clinical Trial92
Adolescent Mental Health Care and Stigma87
Military Sexual Trauma in the United States87
Women With Schizophrenia—Ignored and Aging84
Electroencephalography Microstate Instability and Clinical Outcomes in Individuals at Clinical High Risk of Psychosis82
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older80
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents80
Living Alone and Drug Overdose Deaths in the US79
Hyperalgesia in Patients With a History of Opioid Use Disorder78
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity78
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?76
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity75
JAMA Psychiatry73
Combination Antidepressant Therapy vs Monotherapy—Further Considerations72
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention72
Limitations for Assessing Optimism and Physical Functioning in Women—Reply72
Toward a Pluralistic Model for the Schizophrenia Spectrum—Dopamine and Beyond71
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs71
Physician Suicide and Associated Features—What Defines a Physician?70
JAMA Psychiatry70
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply70
Measures of General Intelligence and Risk for Alcohol Use Disorder70
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies69
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder67
Trends in Outpatient Psychotherapy Among Adults in the US66
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents66
Neurobiological, Psychosocial, and Behavioral Mechanisms Mediating Associations Between Physical Activity and Psychiatric Symptoms in Youth in the Netherlands66
0.095409870147705